Identifying Drugs to Treat Age-Dependent Neurodegeneration
Description: Presently there is no effective treatment for Alzheimer's disease and other age-related disorders that affect millions worldwide. Developing an effective method for validating neural protective compounds would streamline the development of life saving therapies. The research outlined in this proposal used Drosophila to develop several medium-throughput in vivo screening techniques that can identify novel therapeutic compounds for the treatment of aging disorders.
Funder: National Institute on Aging
Funding type: research
Funder scheme: R44
Start date: 2009-09-01
End date: 2014-06-30
Investigator: KIM D. FINLEY (lead)
Institutions: Expression Drug Designs (United States), EXPRESSION DRUG DESIGNS, LLC
Subfield: Aging
Domain: Life Sciences
Funded outputs count: 5
Funder award ID: R44AG033427
OpenAlex ID: G2711374227
